Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2004 Splitting the Difference: Patient Preference versus Conservation of Resources Robert L. Phillips, Jr, MD, MSPH Patients should not be obligated to change a successful prescription routine in order to save money. Virtual Mentor. 2004;6(6):258-260. doi: 10.1001/virtualmentor.2004.6.6.ccas2-0406. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Case and Commentary Jan 2001 Financial Incentives in Managed Care Kayhan Parsi, JD, PhD A case that explores the impact of financial incentives from insurance companies on the patient-physician relationship and whether or not they should be disclosed to a patient. Virtual Mentor. 2001;3(1):3-. doi: 10.1001/virtualmentor.2001.3.1.hlaw1-0101. Case and Commentary Jul 2001 Is It Covered or Not? Health Plans and Experimental Procedures Kayhan Parsi, JD, PhD An ethical case explores physicians' responsibility to provide quality care to their patients within the limitations of insurance reimbursements. Virtual Mentor. 2001;3(7):224-225. doi: 10.1001/virtualmentor.2001.3.7.hlaw1-0107. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9
Case and Commentary Jun 2004 Splitting the Difference: Patient Preference versus Conservation of Resources Robert L. Phillips, Jr, MD, MSPH Patients should not be obligated to change a successful prescription routine in order to save money. Virtual Mentor. 2004;6(6):258-260. doi: 10.1001/virtualmentor.2004.6.6.ccas2-0406.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.
Case and Commentary Jan 2001 Financial Incentives in Managed Care Kayhan Parsi, JD, PhD A case that explores the impact of financial incentives from insurance companies on the patient-physician relationship and whether or not they should be disclosed to a patient. Virtual Mentor. 2001;3(1):3-. doi: 10.1001/virtualmentor.2001.3.1.hlaw1-0101.
Case and Commentary Jul 2001 Is It Covered or Not? Health Plans and Experimental Procedures Kayhan Parsi, JD, PhD An ethical case explores physicians' responsibility to provide quality care to their patients within the limitations of insurance reimbursements. Virtual Mentor. 2001;3(7):224-225. doi: 10.1001/virtualmentor.2001.3.7.hlaw1-0107.